相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Survival and associated comorbidities in inclusion body myositis
Elie Naddaf et al.
RHEUMATOLOGY (2022)
Clinical utility of anticytosolic 5'-nucleotidase 1A antibody in idiopathic inflammatory myopathies
Chiseko Ikenaga et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2021)
Epidemiology and Natural History of Inclusion Body Myositis: A 40-Year Population-Based Study
Shahar Shelly et al.
NEUROLOGY (2021)
Anti-cN1A Antibodies Are Associated with More Severe Dysphagia in Sporadic Inclusion Body Myositis
Matteo Lucchini et al.
CELLS (2021)
Inclusion body myositis: clinical features and pathogenesis
Steven A. Greenberg
NATURE REVIEWS RHEUMATOLOGY (2019)
Anti-NT5c1A Autoantibodies as Biomarkers in Inclusion Body Myositis
Adam Amlani et al.
FRONTIERS IN IMMUNOLOGY (2019)
Dysphagia in Patients with Sporadic Inclusion Body Myositis: Management Challenges
Nika Mohannak et al.
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2019)
A population-based epidemiologic study of adult neuromuscular disease in the Republic of Ireland
Stela Lefter et al.
NEUROLOGY (2017)
Prevalence of anti-NT5C1A antibodies in Japanese patients with autoimmune rheumatic diseases in comparison with other patient cohorts
Yoshinao Muro et al.
CLINICA CHIMICA ACTA (2017)
Cytosolic 5′-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis
J. B. Lilleker et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Seropositivity for NT5c1A antibody in sporadic inclusion body myositis predicts more severe motor, bulbar and respiratory involvement
N. A. Goyal et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
Anti-TIF1-γ antibody and cancer-associated myositis A clinicohistopathologic study
Ayumi Hida et al.
NEUROLOGY (2016)
Mitochondrial pathology in inclusion body myositis
Ulrika Lindgren et al.
NEUROMUSCULAR DISORDERS (2015)
Survival and cancer risk in an unselected and complete Norwegian idiopathic inflammatory myopathy cohort
Gerd Cecilie Dobloug et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2015)
High prevalence of inclusion body myositis in Norway; a population-based clinical epidemiology study
G. C. Dobloug et al.
EUROPEAN JOURNAL OF NEUROLOGY (2015)
Cytosolic 5′-nucleotidase 1A autoimmunity in sporadic inclusion body myositis
H. Benjamin Larman et al.
ANNALS OF NEUROLOGY (2013)
Autoantibodies to cytosolic 5′-nucleotidase 1A in inclusion body myositis
Helma Pluk et al.
ANNALS OF NEUROLOGY (2013)
Incidence and prevalence of idiopathic inflammatory myopathies in South Australia: a 30-year epidemiologic study of histology- proven cases
Ju Ann Tan et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2013)
188th ENMC International Workshop: Inclusion Body Myositis, 2-4 December 2011, Naarden, The Netherlands
M. R. Rose
NEUROMUSCULAR DISORDERS (2013)
Prognosis and prognostic factors in sporadic inclusion body myositis
C. Lindberg et al.
ACTA NEUROLOGICA SCANDINAVICA (2012)
High-resolution HLA-DRB1 genotyping in an Australian inclusion body myositis (s-IBM) cohort: An analysis of disease-associated alleles and diplotypes
Arada Rojana-Udomsart et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
Pathogenic Considerations in Sporadic Inclusion-Body Myositis, a Degenerative Muscle Disease Associated With Aging and Abnormalities of Myoproteostasis
Valerie Askanas et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)
A 12-year follow-up in sporadic inclusion body myositis: an end stage with major disabilities
Fieke M. Cox et al.
BRAIN (2011)
Long-term observational study of sporadic inclusion body myositis
Olivier Benveniste et al.
BRAIN (2011)
NORDCAN - a Nordic tool for cancer information, planning, quality control and research
Gerda Engholm et al.
ACTA ONCOLOGICA (2010)
The heart in sporadic inclusion body myositis: a study in 51 patients
Fieke M. Cox et al.
JOURNAL OF NEUROLOGY (2010)
Inclusion body myositis
D. Hilton-Jones et al.
NEUROMUSCULAR DISORDERS (2010)
Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathies
Johan Ronnelid et al.
AUTOIMMUNITY REVIEWS (2009)
Dysphagia in Inclusion Body Myositis Clinical Features, Management, and Clinical Outcome
Terry H. Oh et al.
AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION (2008)
Prevalence of sporadic inclusion body myositis and factors contributing to delayed diagnosis
Merrilee Needham et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2008)
Epidemiology of autoimmune diseases in Denmark
William W. Eaton et al.
JOURNAL OF AUTOIMMUNITY (2007)
Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches
Merrilee Needham et al.
LANCET NEUROLOGY (2007)
Dysphagia in inflammatory myopathy: Clinical characteristics, treatment strategies, and outcome in 62 patients
Terry H. Oh et al.
MAYO CLINIC PROCEEDINGS (2007)
Raised troponin T in inclusion body myositis is common and serum levels are persistent over time
C. Lindberg et al.
NEUROMUSCULAR DISORDERS (2006)
Inclusion body myositis - Clinical features and clinical course of the disease in 64 patients
UA Badrising et al.
JOURNAL OF NEUROLOGY (2005)
Inclusion body myositis in Connecticut - Observations in 35 patients during an 8-year period
KJ Felice et al.
MEDICINE (2001)
Incidence of malignant disease in biopsy-proven inflammatory myopathy - A population-based cohort study
R Buchbinder et al.
ANNALS OF INTERNAL MEDICINE (2001)
Epidemiology of inclusion body myositis in the Netherlands:: A nationwide study
UA Badrising et al.
NEUROLOGY (2000)
分享论文
